Back to Search
Start Over
Aripiprazole in depersonalization disorder comorbid with major depression and obsessive-compulsive disorder: 3 cases.
- Source :
-
Clinical neuropharmacology [Clin Neuropharmacol] 2014 Jul-Aug; Vol. 37 (4), pp. 125-7. - Publication Year :
- 2014
-
Abstract
- Depersonalization is a frequent symptom in depression and obsessive-compulsive disorder (OCD), but sometimes, it may be severe and concurrently diagnosed as a disorder. The treatment of depersonalization disorder both alone and comorbid with other psychiatric disorders is as yet unclear. This report presents the successful treatment with aripiprazole of concurrent depersonalization disorder in 3 patients with depression or OCD. The psychiatric disorders were diagnosed through structured clinical interviews. Assessments were by means of Yale-Brown Obsessive-Compulsive Scale, the Clinical Global Impression-Improvement Scale, and the 17-item Hamilton Rating Scale for Depression. Aripiprazole may be a beneficial psychotropic drug in the treatment of depersonalization disorder comorbid with OCD or depression, which is an important problem in clinical practice.
- Subjects :
- Adult
Aripiprazole
Depersonalization complications
Depressive Disorder, Major complications
Female
Humans
Obsessive-Compulsive Disorder complications
Antipsychotic Agents therapeutic use
Depersonalization drug therapy
Depressive Disorder, Major drug therapy
Obsessive-Compulsive Disorder drug therapy
Piperazines therapeutic use
Quinolones therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1537-162X
- Volume :
- 37
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Clinical neuropharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 24992087
- Full Text :
- https://doi.org/10.1097/WNF.0000000000000036